Morgan Stanley’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-312,082
| Closed | -$98.8M | – | 8039 |
|
|
2023
Q4 | $98.8M | Buy |
312,082
+260,397
| +504% | +$82.4M | ﹤0.01% | 1738 |
|
|
2023
Q3 | $8.74M | Sell |
51,685
-52,432
| -50% | -$8.87M | ﹤0.01% | 3244 |
|
|
2023
Q2 | $22.6M | Buy |
104,117
+10,884
| +12% | +$2.36M | ﹤0.01% | 2358 |
|
|
2023
Q1 | $16.9M | Sell |
93,233
-18,970
| -17% | -$3.45M | ﹤0.01% | 2603 |
|
|
2022
Q4 | $22M | Sell |
112,203
-33,941
| -23% | -$6.67M | ﹤0.01% | 2241 |
|
|
2022
Q3 | $32.9M | Sell |
146,144
-6,788
| -4% | -$1.53M | ﹤0.01% | 1679 |
|
|
2022
Q2 | $19.3M | Buy |
152,932
+21,847
| +17% | +$2.76M | ﹤0.01% | 2326 |
|
|
2022
Q1 | $16.6M | Buy |
131,085
+52,114
| +66% | +$6.61M | ﹤0.01% | 2322 |
|
|
2021
Q4 | $10.3M | Buy |
78,971
+29,480
| +60% | +$3.86M | ﹤0.01% | 2917 |
|
|
2021
Q3 | $6.05M | Sell |
49,491
-23,652
| -32% | -$2.89M | ﹤0.01% | 3471 |
|
|
2021
Q2 | $8.34M | Sell |
73,143
-26,212
| -26% | -$2.99M | ﹤0.01% | 3203 |
|
|
2021
Q1 | $11.9M | Buy |
99,355
+86,239
| +658% | +$10.4M | ﹤0.01% | 2471 |
|
|
2020
Q4 | $1.33M | Buy |
13,116
+9,046
| +222% | +$919K | ﹤0.01% | 4480 |
|
|
2020
Q3 | $315K | Sell |
4,070
-4,552
| -53% | -$352K | ﹤0.01% | 4878 |
|
|
2020
Q2 | $961K | Buy |
8,622
+6,660
| +339% | +$742K | ﹤0.01% | 4207 |
|
|
2020
Q1 | $141K | Sell |
1,962
-6,182
| -76% | -$444K | ﹤0.01% | 5038 |
|
|
2019
Q4 | $614K | Buy |
8,144
+6,185
| +316% | +$466K | ﹤0.01% | 4818 |
|
|
2019
Q3 | $32K | Buy |
+1,959
| New | +$32K | ﹤0.01% | 5879 |
|